Joseph A. Tino

1.7k total citations
27 papers, 469 citations indexed

About

Joseph A. Tino is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, Joseph A. Tino has authored 27 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Organic Chemistry and 5 papers in Genetics. Recurrent topics in Joseph A. Tino's work include Chronic Lymphocytic Leukemia Research (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and HIV/AIDS drug development and treatment (4 papers). Joseph A. Tino is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and HIV/AIDS drug development and treatment (4 papers). Joseph A. Tino collaborates with scholars based in United States, Germany and Sweden. Joseph A. Tino's co-authors include G. A. JACOBS, Robert Zahler, James R. Burke, Anjalie Field, Neil Flynn, Brian J. Murphy, Steven H. Spergel, Michael D. Lewis, William A. Slusarchyk and Andrés S. Hernández and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Joseph A. Tino

27 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph A. Tino United States 13 172 169 68 55 52 27 469
Stephen Eisennagel United States 8 97 0.6× 266 1.6× 34 0.5× 17 0.3× 7 0.1× 12 480
Michael D. Serby United States 11 90 0.5× 313 1.9× 31 0.5× 43 0.8× 17 0.3× 13 495
Dallas K. Croom United States 15 128 0.7× 313 1.9× 91 1.3× 6 0.1× 33 0.6× 16 687
Tim F. Ryder United States 11 81 0.5× 196 1.2× 40 0.6× 22 0.4× 15 0.3× 20 659
Christopher L. Heran United States 14 48 0.3× 121 0.7× 9 0.1× 56 1.0× 5 0.1× 22 503
Dennis Colussi United States 20 236 1.4× 328 1.9× 34 0.5× 44 0.8× 7 0.1× 44 827
Scott Martin United Kingdom 15 254 1.5× 407 2.4× 96 1.4× 27 0.5× 16 0.3× 32 955
Alessandro Deplano Italy 16 192 1.1× 203 1.2× 20 0.3× 8 0.1× 5 0.1× 31 709
Michael W. Lago United States 10 91 0.5× 209 1.2× 19 0.3× 115 2.1× 5 0.1× 13 538
Tonika Bohnert United States 9 94 0.5× 228 1.3× 18 0.3× 29 0.5× 3 0.1× 9 558

Countries citing papers authored by Joseph A. Tino

Since Specialization
Citations

This map shows the geographic impact of Joseph A. Tino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph A. Tino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph A. Tino more than expected).

Fields of papers citing papers by Joseph A. Tino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph A. Tino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph A. Tino. The network helps show where Joseph A. Tino may publish in the future.

Co-authorship network of co-authors of Joseph A. Tino

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph A. Tino. A scholar is included among the top collaborators of Joseph A. Tino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph A. Tino. Joseph A. Tino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marcoux, David, Myra Beaudoin Bertrand, Carolyn A. Weigelt, et al.. (2020). Annulation reaction enables the identification of an exocyclic amide tricyclic chemotype as retinoic acid Receptor-Related orphan receptor gamma (RORγ/RORc) inverse agonists. Bioorganic & Medicinal Chemistry Letters. 30(19). 127466–127466. 4 indexed citations
2.
Vasta, James D., Gregory Locke, Mark A. Pattoli, et al.. (2019). A High-Throughput BRET Cellular Target Engagement Assay Links Biochemical to Cellular Activity for Bruton’s Tyrosine Kinase. SLAS DISCOVERY. 25(2). 176–185. 9 indexed citations
3.
Yip, Shiuhang, Dauh‐Rurng Wu, Peng Li, et al.. (2018). Separation of Bruton’s tyrosine kinase inhibitor atropisomers by supercritical fluid chromatography. Journal of Chromatography A. 1586. 106–115. 11 indexed citations
4.
Gillooly, Kathleen M., Claudine Pulicicchio, Mark A. Pattoli, et al.. (2017). Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care. PLoS ONE. 12(7). e0181782–e0181782. 47 indexed citations
5.
Liu, Qingjie, Douglas G. Batt, Jonathan Lippy, et al.. (2015). Design and synthesis of carbazole carboxamides as promising inhibitors of Bruton’s tyrosine kinase (BTK) and Janus kinase 2 (JAK2). Bioorganic & Medicinal Chemistry Letters. 25(19). 4265–4269. 23 indexed citations
6.
Muckelbauer, J.K., John S. Sack, James R. Burke, et al.. (2011). X‐Ray Crystal Structure of Bone Marrow Kinase in the X Chromosome: A Tec Family Kinase. Chemical Biology & Drug Design. 78(5). 739–748. 17 indexed citations
7.
Longo, Kenneth, Elizabeth Govek, Anna Nolan, et al.. (2009). Enhanced Gastrointestinal Motility with Orally Active Ghrelin Receptor Agonists. Journal of Pharmacology and Experimental Therapeutics. 329(3). 1178–1186. 50 indexed citations
8.
Li, James J., Haixia Wang, Jun Li, et al.. (2008). Tetrazole based amides as growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 18(8). 2536–2539. 9 indexed citations
9.
Li, Jun, Stephanie Chen, Brian J. Murphy, et al.. (2008). (d)-2-tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: Synthesis and incorporation into the growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 18(14). 4072–4074. 11 indexed citations
10.
Zhai, Weixu, Neil Flynn, Daniel Angelo Longhi, et al.. (2008). Discovery and optimization of (R)-prolinol-derived agonists of the Growth Hormone Secretagogue receptor (GHSR). Bioorganic & Medicinal Chemistry Letters. 18(18). 5083–5086. 5 indexed citations
11.
Hernández, Andrés S., Mujing Yan, Ramakrishna Seethala, et al.. (2008). Optimization of 1H-tetrazole-1-alkanenitriles as potent orally bioavailable growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 18(6). 2067–2072. 3 indexed citations
12.
Mukherjee, Ranjan, Bowman Miao, Daniel S. Meyers, et al.. (2008). Novel Peroxisome Proliferator-Activated Receptor α Agonists Lower Low-Density Lipoprotein and Triglycerides, Raise High-Density Lipoprotein, and Synergistically Increase Cholesterol Excretion with a Liver X Receptor Agonist. Journal of Pharmacology and Experimental Therapeutics. 327(3). 716–726. 25 indexed citations
13.
Hernández, Andrés S., Peter T. W. Cheng, R.J. George, et al.. (2007). Discovery, synthesis, and structure–activity studies of tetrazole based growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 17(21). 5928–5933. 22 indexed citations
14.
Wlodawer, Alexander, Jukka Kervinen, Narmada Thanki, et al.. (1996). Structural Analysis of the Native and Drug Resistant HIV-1 Proteinases Complexed With an Aminodiol Inhibitor. Protein and Peptide Letters. 3(6). 399–406. 16 indexed citations
15.
Ahmad, Saleem, Masud Alam, Gregory S. Bisacchi, et al.. (1995). α-hydroxyamide derived aminodiols as potent inhibitors of hiv protease. Bioorganic & Medicinal Chemistry Letters. 5(15). 1729–1734. 9 indexed citations
16.
Bechtold, Clifford, Amy K. Patick, Masud Alam, et al.. (1995). Antiviral properties of aminodiol inhibitors against human immunodeficiency virus and protease. Antimicrobial Agents and Chemotherapy. 39(2). 374–379. 12 indexed citations
17.
Tino, Joseph A., Junius M. Clark, Anjalie Field, et al.. (1993). Synthesis and antiviral activity of novel isonucleoside analogs. Journal of Medicinal Chemistry. 36(9). 1221–1229. 46 indexed citations
18.
SLUSARCHYK, W. A., Gregory S. Bisacchi, Anjalie Field, et al.. (1992). Synthesis and antiviral activity of 1-cyclobutyl-5-(2-bromovinyl)uracil nucleoside analogs and related compounds.. Journal of Medicinal Chemistry. 35(10). 1799–1806. 15 indexed citations
19.
JACOBS, G. A., Joseph A. Tino, & Robert Zahler. (1989). Synthesis of SQ-32,829, a new nucleoside antiviral agent. Tetrahedron Letters. 30(50). 6955–6958. 40 indexed citations
20.
Nickon, Alex, PAMELA ZURER, Bruce J. Hrnjez, & Joseph A. Tino. (1983). Carbocation routes to large bicyclic olefins. Tetrahedron. 39(16). 2679–2690. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen Eisennagel Breakdown of academic impact, for papers by Michael D. Serby Breakdown of academic impact, for papers by Dallas K. Croom Breakdown of academic impact, for papers by Tim F. Ryder Breakdown of academic impact, for papers by Christopher L. Heran Breakdown of academic impact, for papers by Dennis Colussi Breakdown of academic impact, for papers by Scott Martin Breakdown of academic impact, for papers by Alessandro Deplano Breakdown of academic impact, for papers by Michael W. Lago Breakdown of academic impact, for papers by Tonika Bohnert
Rankless by CCL
2026